A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults

Trial Identifier:	D8111C00010
Sponsor:	AstraZeneca
NCTID::	NCT05057897
Start Date:	January 2022
Primary Completion Date:	April 2023
Study Completion Date:	April 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Russian (Ukraine) Translation
	Thai Translation
	Ukrainian Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
TH	Bangkok, TH, 10700
TH	Khon Kaen, TH, 40002
TH	Muang, TH, 50200
UA	Kharkiv, UA, 61052

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.